LMAT
Price
$79.77
Change
-$0.00 (-0.00%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
1.48B
14 days until earnings call
NHNKY
Price
$10.90
Change
-$0.62 (-5.38%)
Updated
Jul 18 closing price
Capitalization
2.23B
Interact to see
Advertisement

LMAT vs NHNKY

Header iconLMAT vs NHNKY Comparison
Open Charts LMAT vs NHNKYBanner chart's image
LeMaitre Vascular
Price$79.77
Change-$0.00 (-0.00%)
Volume$1.67K
Capitalization1.48B
Nihon Kohden
Price$10.90
Change-$0.62 (-5.38%)
Volume$3.49K
Capitalization2.23B
LMAT vs NHNKY Comparison Chart in %
Loading...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LMAT vs. NHNKY commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a Hold and NHNKY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (LMAT: $79.77 vs. NHNKY: $12.69)
Brand notoriety: LMAT and NHNKY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LMAT: 78% vs. NHNKY: 86%
Market capitalization -- LMAT: $1.48B vs. NHNKY: $2.23B
LMAT [@Medical Specialties] is valued at $1.48B. NHNKY’s [@Medical Specialties] market capitalization is $2.23B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LMAT’s FA Score shows that 2 FA rating(s) are green whileNHNKY’s FA Score has 2 green FA rating(s).

  • LMAT’s FA Score: 2 green, 3 red.
  • NHNKY’s FA Score: 2 green, 3 red.
According to our system of comparison, both LMAT and NHNKY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LMAT’s TA Score shows that 5 TA indicator(s) are bullish while NHNKY’s TA Score has 6 bullish TA indicator(s).

  • LMAT’s TA Score: 5 bullish, 4 bearish.
  • NHNKY’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, NHNKY is a better buy in the short-term than LMAT.

Price Growth

LMAT (@Medical Specialties) experienced а -4.68% price change this week, while NHNKY (@Medical Specialties) price change was +3.36% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.34%. For the same industry, the average monthly price growth was +3.12%, and the average quarterly price growth was -2.87%.

Reported Earning Dates

LMAT is expected to report earnings on Oct 30, 2025.

NHNKY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (+0.34% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NHNKY($2.23B) has a higher market cap than LMAT($1.48B). LMAT has higher P/E ratio than NHNKY: LMAT (49.19) vs NHNKY (18.12). NHNKY YTD gains are higher at: -11.568 vs. LMAT (-12.948). NHNKY has higher annual earnings (EBITDA): 27.2B vs. LMAT (49M). NHNKY has more cash in the bank: 43.7B vs. LMAT (105M). LMAT has less debt than NHNKY: LMAT (19.1M) vs NHNKY (433M). NHNKY has higher revenues than LMAT: NHNKY (202B) vs LMAT (193M).
LMATNHNKYLMAT / NHNKY
Capitalization1.48B2.23B66%
EBITDA49M27.2B0%
Gain YTD-12.948-11.568112%
P/E Ratio49.1918.12272%
Revenue193M202B0%
Total Cash105M43.7B0%
Total Debt19.1M433M4%
FUNDAMENTALS RATINGS
LMAT vs NHNKY: Fundamental Ratings
LMAT
NHNKY
OUTLOOK RATING
1..100
2173
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
22100
SMR RATING
1..100
5717
PRICE GROWTH RATING
1..100
7985
P/E GROWTH RATING
1..100
8561
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NHNKY's Valuation (9) in the null industry is in the same range as LMAT (21) in the Medical Specialties industry. This means that NHNKY’s stock grew similarly to LMAT’s over the last 12 months.

LMAT's Profit vs Risk Rating (22) in the Medical Specialties industry is significantly better than the same rating for NHNKY (100) in the null industry. This means that LMAT’s stock grew significantly faster than NHNKY’s over the last 12 months.

NHNKY's SMR Rating (17) in the null industry is somewhat better than the same rating for LMAT (57) in the Medical Specialties industry. This means that NHNKY’s stock grew somewhat faster than LMAT’s over the last 12 months.

LMAT's Price Growth Rating (79) in the Medical Specialties industry is in the same range as NHNKY (85) in the null industry. This means that LMAT’s stock grew similarly to NHNKY’s over the last 12 months.

NHNKY's P/E Growth Rating (61) in the null industry is in the same range as LMAT (85) in the Medical Specialties industry. This means that NHNKY’s stock grew similarly to LMAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LMATNHNKY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
61%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
51%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
64%
Advances
ODDS (%)
Bullish Trend 12 days ago
73%
Bullish Trend 12 days ago
58%
Declines
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 4 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 6 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIRCX21.570.04
+0.19%
BlackRock Sustainable Adg Lg Cp Cr C
HDGTX36.10N/A
N/A
Hartford Dividend and Growth R5
VALAX27.55N/A
N/A
Al Frank Adv
MURRX24.22N/A
N/A
MFS Utilities R2
KMKYX81.95N/A
N/A
Kinetics Market Opportunities Inst

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
+0.06%
ITGR - LMAT
48%
Loosely correlated
-0.84%
SYK - LMAT
47%
Loosely correlated
-0.53%
UFPT - LMAT
43%
Loosely correlated
-0.49%
AORT - LMAT
40%
Loosely correlated
+0.49%
ALGN - LMAT
40%
Loosely correlated
-0.92%
More